Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India

pharmaceutical-technologyMay 06, 2021

Tag: HDT , Gennova , COVID-19 , RNA , India

PharmaSources Customer Service